The purpose of this modification is to update the key personnel under section g contract administration article g.4 key personnel to include johnnie lead as clinical lead.

Ended Definitive Contract Awarded Last action

Contract number
HHSO100201700013C
Awardee
Awarding agency
Obligated
$132,282,550

Award facts

Opportunity
  • 17100SOL00013 Solicitation number
  • EBOLA Vaccine Award Notice · Posted Apr 18, 2017
Contract value 67% obligated
  • $132,282,550.00 Current, with exercised options
  • $196,408,488.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Netherlands

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00009 $0
Supplemental Agreement for work within scope P00008 · The purpose of this modification is to update the statement of work to provide additional information $0
Other Administrative Action P00007 · The purpose of this modification is to update key personnel and change the submission of the monthly report to quarterly. $0
Other Administrative Action P00006 · The purpose of this modification is to extend the period of performance for the base period, option period 2 and option period 3. $0
Other Administrative Action P00005 · Remove hhsar clause 352.232-71 - electronic submission of payment requests $0
Supplemental Agreement for work within scope P00004 · Incorporate technical changes to SOW; CLIN0001, CLIN0004 and CLIN0005 and add hhsar clause 352.232-71 - electronic submission of payment requests $0
Other Administrative Action P00003 · Janssen will conduct development activities necessary to achieve licensure of the vaccine and manufacture and fill/finish vaccine to be stored as vendor managed… $6,948,581
Supplemental Agreement for work within scope P00002 · The purpose of modification 2 is to additional funds to clin 0004. These funds will be used for the preparation of datasets, analyses and clinical study reports… $2,226,166
Exercise an Option 1 $78,451,793
Original award $44,656,010

About this award

Written by GovTribe AI ·

This is a cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Janssen Vaccines & Prevention B.V. (JPC), a foreign-owned for-profit organization. The $196,408,488.00 contract does not have a set-aside designation and has an ultimate completion date of March 30, 2026. The contract was awarded on September 28, 2017.

Quick answers

Who was awarded contract HHSO100201700013C?

HHSO100201700013C was awarded to Janssen Vaccines & Prevention B.V. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 28, 2017.

How much is contract HHSO100201700013C worth?

The government has obligated $132,282,550 on HHSO100201700013C. Its potential value, with all options, is $196,408,488.

Was contract HHSO100201700013C competed?

The extent of competition for HHSO100201700013C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login